Fig. 4From: The risk of bleeding for antiplatelet agents in Haemodialysis patients: a Meta-analysisa. Subgroup analysis of the use of antiplatelet agents and the risk of bleeding in haemodialysis patients when all studies other than Kauffman 2003 were considered; b. Subgroup analysis of the use of antiplatelet agents and the risk of bleeding in haemodialysis patients in 6 RCTs when Kaufman 2003 was excludedBack to article page